Skip to main content

Research

The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

About 200 million people with diabetes around the world require daily insulin. Once-weekly basal insulins, if approved, could require fewer injections and potentially...
Preventing type 1 diabetes – the main goal for some who do not believe a cure is possible – would ultimately bring this ancient disease to its end. The world’s top...
A fascinating session at the EASD 2022 conference on emerging technologies sheds light on where we are with AID and telemedicine, and what leading researchers in...
The term “type 2 diabetes remission” continues to spark debate in the diabetes community. At the EASD 2022 annual conference in Stockholm, experts explored this concept...
Researchers presented on the exciting weight loss efficacy of tirzepatide. While tirzepatide has not yet been approved for weight loss, the SURMOUNT clinical trial...
A recent research study on open-source AID, a method of insulin delivery used by thousands of people with type 1 diabetes, showed that using open-source AID improved...
Too many people experience blame, shame, and judgment following a gestational diabetes diagnosis. Find out about new research looking into the stigma around pregnancy-...
Impressive results from the DELIVER trial show that dapagliflozin (Farxiga), a SGLT-2 inhibitor, could be used to treat all types of heart failure, a common diabetes...
Clinical trial results have shown that once-weekly basal insulins are just as effective at reducing A1C as once-daily insulin.
Automated insulin delivery (AID) systems have helped many people with diabetes improve their glucose management and Time in Range, both during the day and overnight...
In the search for new and innovative ways to treat type 1 diabetes, researchers have looked to develop therapies that protect or improve the body’s ability to produce...
Insulin pens and pumps are two of the most popular choices for insulin delivery. The CeQur Simplicity aims to combine the strengths of both of these technologies.
Vertex Pharmaceuticals announced its intention to acquire the biotechnology company ViaCyte for $320 million in cash, merging two leaders in beta cell replacement...
Researchers are dedicated to developing new mealtime insulins that can help improve glucose management and prevent highs and lows. Exciting new concentrated, ultra-rapid...
See if you are eligible to participate in this study looking at whether the One Touch Solutions platform and its associated partner programs can help people better...
A study looked at diabetes-related hospitalizations in France before and after people started using a FreeStyle Libre continuous glucose monitor (CGM). Results showed...
What is the risk of passing diabetes on to your children? Research shows that diabetes has a genetic component, but what does that mean?
Positive results from a study of Weight Watchers’ diabetes-tailored program shows reductions in weight, A1C, diabetes distress. Read on to learn more.
From navigating the healthcare system to figuring out how to manage diabetes medications while on gender-affirming hormone therapy, being a transgender person with...
Mental health conditions, self-harm behaviors, and suicide are all too common in the diabetes community. Learn what the statistics mean; be sure to share these suicide...

Pages